AHG (Akso Health Group) Moat Score: 3/10 (As of Jun. 30, 2026)


AHG Akso Health Group AHG
36 GF Score
Price $1.45
GF Value $0.47
Valuation Significantly Overvalued
! 3 Warning Signs
View Full Analysis

What is Akso Health Group Moat Score?

Akso Health Group AHG -4.61% 36 Moat Score is 3 as of Jun. 30, 2026. GuruFocus rates AHG with a GF Score™ of 36/100 and a GF Value™ of $0.47 (Significantly Overvalued). The stock has 3 warning signs investors should review. Among 119 Medical Distribution companies, Akso Health Group ranks better than 85.71% on this metric.

Akso Health Group has the Moat Score of 3, which implies that the company might have No Moat - Very weak/transient advantages.

Akso Health Group has No Moat: Akso Health Group operates in a competitive healthcare sector with limited market share and no significant intellectual property or regulatory barriers. The company lacks strong brand strength and customer loyalty.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Akso Health Group might have No Moat - Very weak/transient advantages.

Akso Health Group  (NAS:AHG) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Akso Health Group Moat Score Related Terms

AHG vs ACH, FOCL, YI: Moat Score Comparison

For the Medical Distribution subindustry, Akso Health Group's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Akso Health Group Moat Score vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Akso Health Group's Moat Score distribution charts can be found below:

* The bar in red indicates where Akso Health Group's Moat Score falls into.


AHG
36GF Score
Akso Health Group AHG
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Moat Score →
What does a Moat Score of 3 mean?
Akso Health Group (AHG) has a Moat Score of 3 as of Jun. 30, 2026. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. According to the industry distribution chart, Akso Health Group ranks #17 out of 119 companies in the Medical Distribution industry, placing it in the top 14.3%.
Is Akso Health Group's Moat Score too high?
Akso Health Group's current Moat Score is 3. Based on the distribution chart, Akso Health Group ranks #17 out of 119 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, Akso Health Group has a GF Score™ of 36/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Akso Health Group's Moat Score compare to ACH and FOCL?
According to the Medical Distribution industry distribution chart, Akso Health Group ranks #17 out of 119 companies for Moat Score. This places Akso Health Group in the top 14% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Moat Score for a Medical Distribution company?
A good Moat Score depends on the Medical Distribution industry context. However, Moat Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Moat Score mean?
A high Moat Score can signal that a stock is expensive relative to its fundamentals. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. Akso Health Group's current Moat Score is 3. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Akso Health Group stock overvalued right now?
Based on GuruFocus' analysis, Akso Health Group (AHG) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.47, compared to a current price of $1.45 — trading 208.5% above its estimated fair value. The current Moat Score is 3. Akso Health Group's overall GF Score™ is 36/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Moat Score calculated?
Moat Score is calculated from a company's financial statements. For Akso Health Group (AHG), the current Moat Score is 3 as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Akso Health Group (AHG) Overvalued in 2026?

Based on GuruFocus' analysis, Akso Health Group stock appears to be overvalued. The current stock price of $1.45 is trading 208.5% above its estimated GF Value™ of $0.47. GuruFocus considers Akso Health Group to be Significantly Overvalued.

Key valuation signals for AHG:

  • Moat Score: 3
  • GF Value™: $0.47 vs. price of $1.45 (208.5% above fair value)
  • GF Score™: 36/100 with 3 warning signs

No single metric tells the full story. See the AHG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Akso Health Group Business Description

Address No. 44, Moscow Road, Qianwan Bonded Port Area, Room 8201-4-4(A), 2nd Floor, Qiantongyuan Building, Qingdao Pilot Free Trade Zone, Shandong, CHN
Akso Health Group is a social e-commerce platform based in China. The company collaborates with domestic e-commerce platforms and offers users a wide selection of high-quality and affordable products on its social e-commerce platform. It generates majority of the revenues from sale of medical devices business.
36GF Score

Get the complete analysis for AHG

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.45
Price
$0.47
GF Value